Active Supportive Care and Symptom Management Grants

PI Name Organization - Company Title FOAsort descending
Mao, Jun J Sloan-Kettering Inst Can Research Dopamine Metabolism and Nonpharmacologic Insomnia Interventions Among Cancer Survivors PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies
Hill, Deirdre University Of New Mexico Health Scis Ctr Chronic Kidney Disease Development in Cancer Treatment and Survival PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies
Lee, Richard T Beckman Research Institute/City Of Hope A Pilot Study to Evaluate the Benefits of Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies
Grueber, Wesley B Columbia University Health Sciences Neuron-macrophage interactions in models of chemotherapy-induced peripheral neuropathy PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies
Valdimarsdottir, Heiddis Icahn School Of Medicine At Mount Sinai Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Symptom Burden among Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program
Hu, Jim Weill Medical Coll Of Cornell Univ Pelvic fascia spARing radical prostatectomy TrIAL (PARTIAL) PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program
Rini, Christine Northwestern University At Chicago Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program
Ross, Stephen New York University School Of Medicine Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program
Sohl, Stephanie Jean Wake Forest University Health Sciences REmotely-delivered Supportive Programs for Improving surgical pain and disTrEss (RESPITE) PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program
Prigerson, Holly Gwen Weill Medical Coll Of Cornell Univ Behavioral and Psychosocial Effects on Study Outcomes in End-Stage Cancer Treatment (BEST End-Stage Cancer Study) PAR-21-333: NCI Outstanding Investigator Award
Grace, Peter University Of Tx Md Anderson Can Ctr PQ12 Targeting HDAC6 for Chemotherapy-Induced Neuropathy and Chemobrain RFA-CA-17-017: Research Answers to NCI's Provocative Questions
Mohile, Supriya G University Of Rochester Understanding Treatment Tolerability in Older Patients with Cancer RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability
Basch, Ethan M. Univ Of North Carolina Chapel Hill Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability
Gray, Robert J Dana-Farber Cancer Inst Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV) RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability
Tighiouart, Mourad Cedars-Sinai Medical Center Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability

Pages